BioInnova logo

BioInnova

Integrative Innovation and Medicine

20 employees · est. 2017 · Australia

VS
RareStone Group logo

RareStone Group

To become the leading company in China rare disease market

25 employees · est. 2019 · China

BioInnova is the older company (2017 vs 2019).

Side-by-Side Comparison

BioInnova RareStone Group
Founded
2017 older 2019
Headquarters
Australia China
Employees
20 25
Industry
Manufacturing, Pharmaceutical Pharmaceutical
Funding Stage
Not tracked yet Series A
Total Funding
Not tracked yet $80.00M
Funding Rounds
Not tracked yet 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Pharmaceuticals, Precision Medicine, Rare Diseases, Oncology, Neurology, Autoimmune Disorders, Regulatory Compliance, Patient Engagement, Scientific Advancement Rare Diseases, Pharmaceuticals, Healthcare Services, China Market, Therapeutic Solutions, Service Platform, Rare Disease Community, Series A Financing, Investors, Neurology, Endocrinology, AI And Big Data Analytics, Patient-centered Care, Ecosystem Development
Website
bioinnova.com.au rarestonegroup.com
BioInnova logo

About BioInnova

BioInnova is a pioneering pharmaceutical company founded in 2017, headquartered in Australia, with a slogan of "Integrative Innovation and Medicine." The company is dedicated to driving groundbreaking discoveries and advancements in healthcare, with a strong focus on innovation, research, and patien...

RareStone Group logo

About RareStone Group

RareStone Group is on a mission to revolutionize the rare disease market in China. The company's subsidiaries, Citrine Medicine and Zircon Health, are pioneering a comprehensive ecosystem for rare diseases. Citrine Medicine focuses on delivering effective and affordable therapeutic solutions across...

We will tell you when either one moves

BounceWatch watches BioInnova and RareStone Group for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BioInnova and RareStone Group — by email.

Frequently Asked Questions

BioInnova — Integrative Innovation and Medicine. RareStone Group — To become the leading company in China rare disease market . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BioInnova has raised undisclosed funding while RareStone Group has raised $80.00M.
BioInnova and RareStone Group operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BioInnova with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at BioInnova on 12 Sep 2024, and RareStone Group on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy